Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novocure Ltd Ord Sh
(NQ:
NVCR
)
19.44
-0.31 (-1.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novocure Ltd Ord Sh
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
3 Growth Stocks to Buy That Could Skyrocket
November 28, 2022
The future looks promising for all three of these stocks.
Via
The Motley Fool
Novocure Stock: Bull vs. Bear
November 26, 2022
The company's technology has a lot of potential. But does its stock?
Via
The Motley Fool
2 Potentially Explosive Stocks to Buy in November
November 08, 2022
Both Novocure and MercadoLibre could have good news on the way.
Via
The Motley Fool
NovoCure's Return On Capital Employed Insights
November 02, 2022
NovoCure (NASDAQ:NVCR) brought in sales totaling $131.00 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 10.7%, resulting in a loss of $26.58 million.
Via
Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
October 29, 2022
The opportunities for these innovators are tremendous.
Via
The Motley Fool
What 4 Analyst Ratings Have To Say About NovoCure
October 28, 2022
Analysts have provided the following ratings for NovoCure (NASDAQ:NVCR) within the last quarter:
Via
Benzinga
Where NovoCure Stands With Analysts
October 28, 2022
NovoCure (NASDAQ:NVCR) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Novocure (NVCR) Q3 2022 Earnings Call Transcript
October 27, 2022
NVCR earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Why Novocure Stock Is Sinking Today
October 24, 2022
An analyst's downgrade is weighing on the biotech company.
Via
The Motley Fool
The Clock Is Ticking to Buy This Game-Changing Stock at a Discount
October 06, 2022
This stock could soon skyrocket.
Via
The Motley Fool
NovoCure: Q3 Earnings Insights
October 27, 2022
NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings NovoCure beat estimated earnings...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
October 24, 2022
Upgrades
Via
Benzinga
CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday
October 24, 2022
Raymond James raised CSX Corporation (NASDAQ: CSX) price target from $31 to $33. Raymond James analyst Patrick Tyler Brown maintained the stock with an Outperform rating. CSX shares rose 1.7% to close...
Via
Benzinga
Recap: NovoCure Q2 Earnings
July 28, 2022
NovoCure (NASDAQ:NVCR) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
NovoCure: Q1 Earnings Insights
April 28, 2022
NovoCure (NASDAQ:NVCR) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Novocure's TTFields Show Improved Progression-Free, Overall Survival Over Matched-Control
March 25, 2022
Novocure Ltd (NASDAQ: NVCR)
Via
Benzinga
3 Unstoppable Stocks You Can Buy Now for Less Than $100
October 13, 2022
They might not be available so cheaply for too much longer.
Via
The Motley Fool
NovoCure Earnings Perspective: Return On Capital Employed
August 04, 2022
NovoCure (NASDAQ:NVCR) brought in sales totaling $140.87 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 416.63%, resulting in a loss of $24.01 million.
Via
Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
July 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Biotech Stocks To Watch And Pharma Industry News
July 08, 2022
Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022
July 05, 2022
Upgrades
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid...
Via
Benzinga
The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review
May 26, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
April 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022
May 16, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Up On Bad News
March 22, 2022
Despite the plane crash in China, Boeing's stock is up today.
Via
Talk Markets
Lucky Day
March 21, 2022
Today Alleghany rose nearly 25% because it is being bought by Berkshire Hathaway, Warren Buffett's fund.
Via
Talk Markets
World Markets News For Friday
March 18, 2022
Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%.
Via
Talk Markets
Novocure Q4 Earnings Miss Street View, New Data Shows TTFields Initiates Downstream Anti-Tumor Response
February 24, 2022
A new study published in the Journal of Clinical Investigation (JCI) finds treatment with Novocure Ltd's (NASDAQ: NVCR) Tumor Treating Fields (TTFields) mediated...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.